The Nightly Use of Sodium Oxybate Is Associated with a Reduction in Nocturnal Sleep Disruption: A Double-Blind, Placebo-Controlled Study in Patients with Narcolepsy

Eitemau Tebyg

• Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
  gan: Bogan, Richard K, et al.
  Cyhoeddwyd: (2020)
• Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy
  gan: Husain, Aatif M., et al.
  Cyhoeddwyd: (2020)
• Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy
  gan: Bogan, Richard K, et al.
  Cyhoeddwyd: (2021)
• Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate
  gan: Tomi eSarkanen, et al.
  Cyhoeddwyd: (2014-08-01)
• Psychosis in Patients with Narcolepsy as an Adverse Effect of Sodium Oxybate
  gan: Sarkanen, Tomi, et al.
  Cyhoeddwyd: (2014)